drugset / Trial / NCT06181422
Metformin and Lactoferrin in Sepsis in Icu
RandomizedParallel-groupOpen-labelPrevention
Summary
Sepsis is a life-threatening organ dysfunction triggered by an unregulated response of a host to infection. Sepsis is a reason for substantial mortality and morbidity among intensive care unit (ICU) patients. 1 Therefore, the aim of our study is to compare the safety and efficacy of metformin and lactoferrin in ICU patients with sepsis.
Timeline
- Start
- 2024-04
- Primary completion
- 2024-06-09
- Completion
- 2024-06-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lactoferrin | Protein / enzyme biologic | 100 mg | — |
| Comparator | Metformin | Small molecule | 500 mg | — |